CRISPR Therapeutics AG (CRSP) Minority Interest (2015 - 2016)
CRISPR Therapeutics AG's (CRSP) quarterly Minority Interest came in at -$51000.0 in Q3 2016, down 88.89% quarter-over-quarter from -$27000.0 in Q4 2015.
CRISPR Therapeutics AG (CRSP) Minority Interest (2015 - 2016) Analysis & Trends
CRISPR Therapeutics AG has disclosed Minority Interest across 2 years of filings, most recently posting -$51000.0 for Q3 2016.
- Minority Interest for Q3 2016 came in at -$51000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was -$51000.0 (changed N/A YoY), and the FY2015 annual result was -$27000.0, changed N/A from the prior year.
- Minority Interest came in at -$51000.0 for Q3 2016 at CRISPR Therapeutics AG, down from -$27000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$27000.0 in Q4 2015 to a low of -$51000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | CRISPR Therapeutics AG | 5.21 Bn | 2.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -51,000.00 |
| Dec 31, 2015 | -27,000.00 |